Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Feb 23, 2009

34519_dirs_2009-02-23_0bf1b108-dc74-4d0b-899b-9a850e19c6b1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-02-19

Reporting Person: Rhodes Linda (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-19 Common stock, $0.10 par value P 200 $2.00 Acquired 2800 Direct
2009-02-20 Common stock, $0.10 par value P 200 $2.00 Acquired 3000 Direct